P-D-R Pharma Documentation Ring

The P-D-R is an association whose members represent the scientific information departments of the leading international R&D-based pharmaceutical corporations.

Latest News from the P-D-R Company Websites

Published 19 December 2014 | 10:00 pm

Adolescents and Young Adults at Risk for Meningococcal Disease

Meningococcal disease, spread by typical adolescent and young adult behaviors such as close quartered living, sharing utensils and kissing, is often mistaken early on for the more ...

Published 19 December 2014 | 9:45 pm

Vaccines: What You Need to Know

Published on 17 Dec 2014 On Inside Edition, Pfizer's Chief Medical Officer, Freda Lewis-Hall, M.D., talks to Deborah Norville about why keeping current on vaccinations is the more ...

Published 19 December 2014 | 6:54 pm

LYNPARZATM approved by the US food and drug administration for the treatment of advanced ovarian cancer in patients with germline BRCA-mutations

AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved LYNPARZATM (olaparib) capsules (400mg twice daily) as the first monotherapy for more ...

Published 19 December 2014 | 2:28 pm

The page you're looking for can't be found.

Did you try searching? You will find the search box on the upper right corner of this page. Enter one or more keywords and click the search icon. Or simply try one of the links more ...

Published 19 December 2014 | 11:58 am

Cookies Top five sustainability stories of 2014

more ...

Published 19 December 2014 | 9:55 am

Opening up more research data

At UCB we are delivering on our commitment to improving access to research data. In recent months we have begun to share data on our own website and on a site to which more ...

Published 19 December 2014 | 8:10 am

Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology

INDIANAPOLIS and LYON, France, Dec. 19, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Adocia ( Euronext Paris: FR0011184241 - ADOC) today announced a more ...

Published 19 December 2014 | 7:29 am

ONO and Gilead Announce Exclusive License Agreement to Develop BTK Inhibitor, ONO-4059, for the Treatment of B-cell Malignancies and Other Diseases

-- Companies will Collaborate Jointly on Global Development of ONO-4059 -- more ...

Published 19 December 2014 | 7:04 am

Media Release

Roche provides update on Phase III MARIANNE study in people with previously untreated advanced HER2-positive breast cancer more ...

Published 19 December 2014 | 7:04 am

Media Release

Roche provides update on gantenerumab development programme more ...

Pharma Documentation Ring:
23 companies - 4 common aims:

  • Promote exchange of experience/networking among members
  • Encourage commercial development of new information services and systems
  • Jointly assess new and existing products and services
  • Provide a forum for the information industry
  • How to become a P-D-R member?
Next Annual General Meeting, Sept 22-25, 2015 – Zuerich/Switzerland

Next Annual General Meeting, Sept 22-25, 2015 – Zuerich/Switzerland

Foto: © MadGeographer